VivoSim Labs, Inc. Contract with Customer, Liability, Noncurrent
VivoSim Labs, Inc. (VIVS) had Contract with Customer, Liability, Noncurrent of $0 as of 2019-03-31, per its 10-K filed 2019-06-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2019-06-03
- 2019-03-31: Contract with Customer, Liability, Noncurrent $0.00.
- 2018-12-31: Contract with Customer, Liability, Noncurrent $0.00.
- 2018-09-30: Contract with Customer, Liability, Noncurrent $0.00.
- 2018-06-30: Contract with Customer, Liability, Noncurrent $10.00K.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2019-03-31 | $0.00 10-K · filed 2019-06-03 |
| 2018-12-31 | $0.00 10-Q · filed 2019-02-07 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 |
| 2018-06-30 | $10.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $19.00K 10-K · filed 2019-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |